Home Healthcare Healthcare Services Neurology Clinical Trials Market

Neurology Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Muscle regeneration, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Jay Mehta | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Neurology Clinical Trials Market Size Analysis
    1. Introduction
    2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
      1. Interventional
      2. Observational
      3. Expanded Access
    4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Epilepsy
      2. Parkinson's Disease (PD)
      3. Huntington's Disease
      4. Stroke
      5. Traumatic Brain Injury (TBI)
      6. Amyotrophic Lateral Sclerosis (ALS)
      7. Muscle regeneration
      8. Others
  7. North America Neurology Clinical Trials Market Size Analysis
    1. Introduction
    2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
      1. Interventional
      2. Observational
      3. Expanded Access
    4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Epilepsy
      2. Parkinson's Disease (PD)
      3. Huntington's Disease
      4. Stroke
      5. Traumatic Brain Injury (TBI)
      6. Amyotrophic Lateral Sclerosis (ALS)
      7. Muscle regeneration
      8. Others
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
  8. Europe Neurology Clinical Trials Market Size Analysis
    1. Introduction
    2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
      1. Interventional
      2. Observational
      3. Expanded Access
    4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Epilepsy
      2. Parkinson's Disease (PD)
      3. Huntington's Disease
      4. Stroke
      5. Traumatic Brain Injury (TBI)
      6. Amyotrophic Lateral Sclerosis (ALS)
      7. Muscle regeneration
      8. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
  9. APAC Neurology Clinical Trials Market Size Analysis
    1. Introduction
    2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
      1. Interventional
      2. Observational
      3. Expanded Access
    4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Epilepsy
      2. Parkinson's Disease (PD)
      3. Huntington's Disease
      4. Stroke
      5. Traumatic Brain Injury (TBI)
      6. Amyotrophic Lateral Sclerosis (ALS)
      7. Muscle regeneration
      8. Others
    5. China
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    8. India
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
  10. Middle East and Africa Neurology Clinical Trials Market Size Analysis
    1. Introduction
    2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
      1. Interventional
      2. Observational
      3. Expanded Access
    4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Epilepsy
      2. Parkinson's Disease (PD)
      3. Huntington's Disease
      4. Stroke
      5. Traumatic Brain Injury (TBI)
      6. Amyotrophic Lateral Sclerosis (ALS)
      7. Muscle regeneration
      8. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
  11. LATAM Neurology Clinical Trials Market Size Analysis
    1. Introduction
    2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
      1. Interventional
      2. Observational
      3. Expanded Access
    4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Epilepsy
      2. Parkinson's Disease (PD)
      3. Huntington's Disease
      4. Stroke
      5. Traumatic Brain Injury (TBI)
      6. Amyotrophic Lateral Sclerosis (ALS)
      7. Muscle regeneration
      8. Others
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
  12. Competitive Landscape
    1. Neurology Clinical Trials Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. IQVIA
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Novartis
    3. Covance
    4. Medpace
    5. Charles River Laboratories
    6. SyneousHealth
    7. Icon Plc
    8. GlaxoSmithKline
    9. Aurora healthcare
    10. Biogen
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.